Clinical Biochemistry

Course & Instructor Information

  • Module: CEM3133 Clinical Biochemistry (Biomedical Science – Medical Biology)

  • Programme: Foundation in Science

  • Institution: MAHSA University, Centre for Pre-University Studies

  • Lecturer: Dr. Vinibha Rajakumari

  • Contact: vinibharajakumari@mahsa.edu.my

Learning Outcomes

  • Explain the diagnostic importance of key enzymes (AST, ALT, LDH, CK).

  • Explain the diagnostic significance of selected body-fluid analyses (CSF, Synovial, Amniotic).

  • Apply and explain concepts of etiology, pathogenesis, morphology for common human diseases.

Clinical Biochemistry & Enzymology

  • Also termed Chemical Pathology – analysis of body fluids for diagnosis/therapy.

  • Clinical Enzymology: application of enzyme measurements for disease diagnosis & management.

  • Utility of serum-enzyme profiling:
    • Myocardial infarction
    • Liver, muscle, bone & GI diseases
    • Cancers

  • Unit of enzyme activity: International Unit (IU)
    1IU=1μmol of substrate converted  min1L11\,\text{IU} = 1\,\mu\text{mol of substrate converted}\;\text{min}^{-1}\,\text{L}^{-1} (optimal conditions, defined temperature).
    • Routine reporting: IUL1\text{IU\,L}^{-1}.

  • Definition of Serum: plasma after coagulation – fibrinogen → fibrin retained in clot.

Key Diagnostic Enzymes (overview)

  • Alanine Transaminase (ALT, SGPT)

  • Aspartate Transaminase (AST, SGOT)

  • Lactate Dehydrogenase (LDH)

  • Creatine Kinase (CK/CPK)

Aspartate & Alanine Transaminases (AST / ALT)

  • Reactions (require pyridoxal-5'-phosphate):
    AST: Oxaloacetate+GlutamateAspartate+α-Ketoglutarate\text{Oxaloacetate} + \text{Glutamate} \rightleftharpoons \text{Aspartate} + \alpha\text{-Ketoglutarate}
    ALT: Pyruvate+GlutamateAlanine+α-Ketoglutarate\text{Pyruvate} + \text{Glutamate} \rightleftharpoons \text{Alanine} + \alpha\text{-Ketoglutarate}

  • Equilibria favour aspartate & alanine production respectively.

  • Reference ranges (adult):
    • AST: 8 – 48 IU/L
    • ALT: 7 – 55 IU/L

Tissue Distribution & Clinical Significance
  • Highest activities: liver, heart, skeletal muscle.

  • Raised in cell injury of these tissues; mild rise post-alcohol intake.

  • ALT is more liver-specific (rarely elevated by non-hepatic causes).

  • AST less specific – rises in liver, heart, muscle disorders.

Differential Patterns
  • Possible conditions when both ↑: extrahepatic cholestasis, cirrhosis, hepatocellular carcinoma.

  • Acute hepatic injury → sharp ALT spike.

  • Chronic/secondary organ damage → gradual AST rise.

AST / ALT Ratio Guidelines (normal ≈ 0.8)

Ratio

Interpretation

<1 (ALT > AST)

Non-alcoholic fatty liver disease

1\approx1

Acute viral hepatitis or drug-toxicity

>1 (AST > ALT)

Cirrhosis

>2:1 (AST ≈2× ALT)

Alcoholic liver disease

Creatine Kinase (CK)

  • Catalyses reversible phosphorylation:
    Creatine+ATP    pH6.7  CK,Mg2+  Phosphocreatine+ADP\text{Creatine} + \text{ATP} \;\xrightleftharpoons[\;pH\,6.7\;]{\text{CK},\,Mg^{2+}}\; \text{Phosphocreatine} + \text{ADP}

  • At neutral pH phosphocreatine has higher phosphoryl-potential → reaction favours ATP regeneration during muscle contraction.

Clinical Significance
  • Elevated total CK signifies tissue damage: skeletal muscle, myocardium, brain.

  • Isoenzyme differentiation (CK-MB, CK-BB, CK-MM) aids diagnosis of:
    • Myocardial infarction
    • Muscular dystrophies / rhabdomyolysis
    • CNS trauma or stroke

Lactate Dehydrogenase (LDH)

  • Catalyses: Pyruvate+NADH+H+    Lactate+NAD+\text{Pyruvate} + \text{NADH} + H^{+} \;\rightleftharpoons\; \text{Lactate} + \text{NAD}^{+}

  • Ubiquitous; high in muscle.

  • Reaction direction depends on cellular redox state.

Clinical Significance
  • Serum LDH released upon tissue damage; rises as cell lysis begins.

  • Elevated in:
    • Anemia
    • Infections (mono, meningitis, encephalitis, HIV)
    • Sepsis
    • Infarctions: intestinal, myocardial, pulmonary
    • Acute kidney, liver, muscle injuries
    • Cancer – high LDH predicts poor prognosis & failed chemotherapy

  • CSF LDH: high → bacterial meningitis; low/normal → viral meningitis.

Body-Fluid Compartments & Composition

  • Total body water ≈ 70 % body weight.

  • Extracellular fluid (ECF):
    Interstitial fluid (~80 % of ECF)
    Plasma (~20 %)
    • Also lymph, synovial, aqueous humour, CSF, pleural, peritoneal fluids.

  • Organic solutes: glucose, amino acids, fatty acids, hormones, enzymes.

  • Inorganic ions: Na⁺, K⁺, Ca²⁺, Mg²⁺, Cl⁻, PO<em>43\text{PO}<em>4^{3-}, SO</em>42\text{SO}</em>4^{2-}.

Laboratory Examination of Fluids

  • Physical properties (colour, viscosity, volume).

  • Biochemical analysis (analytes, enzymes, metabolites).

  • Morphologic/cellular elements.

  • Microbial culture.

  • Ancillary studies (e.g., fetal anomaly screening).

Cerebrospinal Fluid (CSF)

Composition & Formation

  • Third major body fluid.

  • Adults: 125 – 150 mL; Neonates: 10 – 60 mL.

  • Formed by choroid plexus & ependymal cells; fills sub-arachnoid space.

Functions

  • Mechanical cushioning of brain/spinal cord.

  • Circulates nutrients & chemicals filtered from blood.

  • Removes metabolic waste & toxins.

Protein Analysis

  • Normal total protein: 15 – 45 mg/dL (<< plasma).

  • >80 % derives from plasma (but <1 % of plasma concentration).

  • Elevated when:
    • Blood–brain barrier (BBB) damage
    • Intrathecal IgG synthesis
    • Neural tissue degeneration.

Detailed Protein Fractions (mg L⁻¹)
  • Pre-albumin 17.3; Albumin 155; Transferrin 14.4; IgG 12.3; etc.

Causes of ↑ CSF Protein

  • Traumatic tap (blood contamination).

  • ↑ BBB permeability: arachnoiditis (e.g., post-methotrexate), meningitis (bacterial/viral/fungal/TB), subarachnoid or intracerebral hemorrhage.

  • Local IgG synthesis: neurosyphilis, multiple sclerosis (MS), subacute sclerosing panencephalitis.

  • Combined BBB + IgG: Guillain-Barré, collagen vascular disease (SLE, periarteritis).

  • Drug toxicity: ethanol, phenothiazines, phenytoin.

  • CSF circulation defects: obstruction (tumour, abscess, herniated disc), loculated effusions.

Albumin Indices

  • Albumin ratio (BBB evaluation):
    CSF Albumin:Serum Albumin=1:230  (normal)\text{CSF Albumin} : \text{Serum Albumin} = 1:230\; \text{(normal)}

  • Albumin index:
    Index=CSF Albumin (mg/dL)Serum Albumin (g/dL)\text{Index} = \frac{\text{CSF Albumin (mg/dL)}}{\text{Serum Albumin (g/dL)}}
    <9 → intact barrier
    • 9 – 14 → slight impairment
    • 14 – 30 → moderate
    • >30 → severe
    • Traumatic tap invalidates calculation.

IgG Index

  • Detects intrathecal IgG production (e.g., MS):
    IgG Index=CSF IgG (mg/dL)×Serum Albumin (g/dL)Serum IgG (g/dL)×CSF Albumin (mg/dL)\text{IgG Index} = \frac{\text{CSF IgG (mg/dL)} \times \text{Serum Albumin (g/dL)}}{\text{Serum IgG (g/dL)} \times \text{CSF Albumin (mg/dL)}}

  • Normal upper limit 0.8; >0.8 indicates CNS IgG synthesis.

CSF Protein Electrophoresis Patterns

  • Compare CSF vs serum IgG bands:
    Type 1 Normal (polyclonal both).
    Type 2 Intrathecal oligoclonal bands (MS).
    Type 3 Intrathecal + systemic disease.
    Type 4 Systemic inflammation (mirror oligoclonal).
    Type 5 Monoclonal gammopathy (e.g., myeloma).

Glucose

  • Fasting CSF glucose 50 – 80 mg/dL (≈ 60 % of plasma).

  • CSF/plasma ratio 0.3 – 0.9.

  • <40 mg/dL (hypoglycorrhachia) → bacterial/TB/fungal meningitis.

  • Causes: ↑ anaerobic glycolysis by brain & leukocytes, impaired transport.

  • Normalises earlier than protein/cell counts during recovery, useful for monitoring treatment.

Additional Chemical Markers

  • Lactate ↑ → CNS hypoxia/anaerobic metabolism.

  • F₂-isoprostanes ↑ → Alzheimer’s disease marker.

  • Myelin basic protein ↑ → chronic demyelination.

  • ADA ↑ → tuberculous meningitis.

  • LDH ↑ → leukemia, lymphoma, bacterial meningitis, hemorrhage.

  • CSF Glutamine reflects brain ammonia; ↑ in hypercapnia or sepsis.

Procedure Snapshot – Lumbar Puncture

  1. Patient in fetal position.

  2. Local anaesthetic to lower back.

  3. Needle inserted between lumbar vertebrae.

  4. Small CSF volume collected.

Synovial Fluid (SF)

  • Viscous joint fluid secreted by synovial membrane; contains hyaluronic acid & low-level plasma proteins.

Functions

  • Nutrient supply to cartilage.

  • Lubrication for articulating surfaces.

Biochemical Tests

  • Glucose (fasting): normal <0.55 mmol/L; large drop vs serum suggests infection/inflammation.

  • Protein: normal ≈ ⅓ of plasma; ↑ indicates hemorrhagic or inflammatory joint disease (membrane permeability altered).

  • LDH: elevated in rheumatoid arthritis & other inflammatory arthropathies.

  • Uric acid: crystallisation confirms gout.

Amniotic Fluid (AF)

Composition & Formation

  • Clear/slightly yellow liquid in amniotic sac.

  • Origins: fetal-cell metabolism, maternal trans-placental water flow, fetal urine (later gestation).

  • Volume grows with gestation (≈ 500 – 2500 mL).

Functions

  • Cushions fetus from trauma.

  • Medium for nutrient/waste exchange.

  • Allows fetal movement → symmetrical musculoskeletal development.

Indications & Tests

  • Sample volume ≤20 mL (amniocentesis).

  • Indications: suspected chromosomal/metabolic disorders, neural-tube defects, hemolytic disease of newborn (HDN), infection, assessment of fetal maturity/gestational age.

Key Analytes
  • Alpha-fetoprotein (AFP) – neural tube defects; measured in both AF and maternal serum.

  • Cytogenetics – karyotyping for chromosomal anomalies (e.g., trisomy 21).
    • Indicated in mothers >35 yr, recurrent miscarriages, abnormal maternal AFP, parental carrier status.

  • Other chemistry:
    Bilirubin – degree of hemolysis (HDN).
    Creatinine – fetal kidney maturity & gestational age.

General Pathology Concepts

  • Pathology bridges basic science & clinical medicine; studies disease manifestations, causes, mechanisms.

Knowledge Checklist for Any Disease

  • Definition, Epidemiology (where/when), Etiology (cause), Pathogenesis (evolution), Morphology (structural change), Management, Prognosis, Prevention.

Manifestations

  • Signs – objective examiner findings.

  • Symptoms – patient-perceived functional disturbances.

  • Lesions – visible tissue/organ changes (benign, malignant, gross, occult, primary).

  • Exacerbation – sudden worsening during disease course.

Etiological Factors

  • Environmental: physical, chemical, nutritional, infectious, immunological, psychological.

  • Genetic traits, Age.

  • Multifactorial diseases: diabetes, hypertension, cancer.

Pathogenesis Definition

  • Sequence of cellular/tissue events from initial etiologic stimulus → disease expression → outcome (recovery/death).

Key Terminology

  • Acute (rapid onset), Fulminating (acute & fatal), Chronic (slow, long), Intercurrent (superimposed disease), Idiopathic (unknown cause), Teratogenic (drug-induced fetal harm), Contagious (direct contact), Venereal (sexual), Infectious, Communicable (via vectors/fomites).

Case Illustration – Chickenpox (Varicella-Zoster Virus, VZV)

Etiology & Transmission

  • DNA herpesvirus; inhalation of infected respiratory droplets or contact with vesicular fluid.

Pathogenesis Timeline

Day

Event

0-3

Infection of conjunctivae / upper-respiratory mucosa → viral replication in regional lymph nodes

4-6

Primary viremia → dissemination to liver, spleen, other organs

10-12

Secondary viremia

14

Skin infection → vesicular rash appearance

Latency

Virus enters cutaneous neurons → dorsal-root ganglia (latent)

  • Incubation ~10-21 days; contagious 1-2 days pre-rash until crusting.

Morphology of VZV Particle

  • Core: double-stranded DNA genome.

  • Capsid: icosahedral protein shell.

  • Tegument: enzymes for commandeering host metabolism.

  • Envelope: outer lipid bilayer with glycoprotein spikes.

  • Size: 150 – 200 nm diameter.

Ethical & Practical Implications

  • Correct enzyme/body-fluid interpretation guides critical decisions (e.g., MI thrombolysis timing, antimicrobial choice for meningitis, prenatal counseling).

  • Misinterpretation (e.g., traumatic tap artefacts) may lead to overtreatment or missed diagnoses.

  • Prenatal testing requires genetic counseling to address ethical concerns of selective termination.

Quick Reference Values & Equations

  • AST 8-48 IU/L, ALT 7-55 IU/L.

  • AST/ALT ratio diagnostic thresholds (see table above).

  • Albumin ratio 1:230, Albumin index <9 normal.

  • IgG index ≤0.8 normal.

  • CSF glucose 50-80 mg/dL; abnormal <40 mg/dL.

  • Synovial glucose <0.55 mmol/L (fasting).

  • IU definition: 1μmol min1L11\,\mu\text{mol min}^{-1}\,\text{L}^{-1}.

End-of-Lecture Integration

  • Enzyme assays + body-fluid analysis form a diagnostic matrix: correlating biochemical markers with etiology, pathogenesis, morphology gives a holistic understanding, essential for evidence-based practice.